Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2000, p. 1100-1101, Vol. 44, No. 4
Pediatric Oncology Branch, National Cancer
Institute, Bethesda, Maryland 20892-1928
Received 26 February 1999/Returned for modification 23 December
1999/Accepted 18 January 2000
Antifungal prophylaxis in cancer patients who are undergoing
chemotherapy is associated with prolonged neutropenia. We measured the
effect of fluconazole on doxorubicin pharmacokinetics in nonhuman primates to determine if neutropenia is related to a pharmacokinetic interaction that delays the clearance of the chemotherapeutic agent.
Fluconazole pretreatment had no effect on doxorubicin pharmacokinetics.
0066-4804/00/$04.00+0
Effect of Fluconazole on the Pharmacokinetics of
Doxorubicin in Nonhuman Primates
*
Corresponding author. Mailing address: Pediatric
Oncology Branch, Bldg. 10/Rm. 13N240, 10 Center Dr., MSC 1928, Bethesda, MD 20892-1928. Phone: (301) 496-1756. Fax: (301) 402-0575. E-mail: warrenk{at}exchange.nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»